OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,275 | +21.4% | 29,759 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $94,139 | -15.2% | 28,701 | +3.5% | 0.00% | – |
| Q1 2021 | $111,000 | +73.4% | 27,729 | +0.3% | 0.00% | – |
| Q4 2020 | $64,000 | -56.5% | 27,655 | +8.0% | 0.00% | -100.0% |
| Q3 2020 | $147,000 | -23.8% | 25,600 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $193,000 | +1186.7% | 26,183 | +211.7% | 0.00% | – |
| Q1 2019 | $15,000 | -28.6% | 8,401 | -3.1% | 0.00% | – |
| Q4 2018 | $21,000 | -58.0% | 8,674 | -0.8% | 0.00% | – |
| Q3 2018 | $50,000 | -25.4% | 8,741 | +1.8% | 0.00% | – |
| Q2 2018 | $67,000 | +21.8% | 8,583 | +9.5% | 0.00% | – |
| Q1 2018 | $55,000 | +61.8% | 7,840 | +130.4% | 0.00% | – |
| Q4 2017 | $34,000 | +17.2% | 3,403 | +0.5% | 0.00% | – |
| Q3 2017 | $29,000 | -12.1% | 3,386 | +8.1% | 0.00% | – |
| Q2 2017 | $33,000 | – | 3,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |